Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection
Authors
Keywords
-
Journal
Mucosal Immunology
Volume 11, Issue 1, Pages 35-49
Publisher
Springer Nature
Online
2017-04-19
DOI
10.1038/mi.2017.36
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes
- (2016) Amanda Croasdell et al. FASEB JOURNAL
- Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of NontypeableHaemophilus influenzae
- (2016) Amanda Croasdell et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32
- (2016) Mattia Schmid et al. JOURNAL OF IMMUNOLOGY
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- Pseudomonas aeruginosasabotages the generation of host proresolving lipid mediators
- (2016) Becca A. Flitter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
- (2016) Craig Winstanley et al. TRENDS IN MICROBIOLOGY
- Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
- (2016) Cristina Cigana et al. Scientific Reports
- IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa
- (2016) Nicola Ivan Lorè et al. Scientific Reports
- Identification of resolvin D2 receptor mediating resolution of infections and organ protection
- (2015) Nan Chiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation
- (2015) R E Abdulnour et al. Mucosal Immunology
- Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
- (2014) Youn Jeong Kim et al. BMC INFECTIOUS DISEASES
- Combination Therapy of 15-Epi-Lipoxin A4 With Antibiotics Protects Mice From Escherichia coli–Induced Sepsis*
- (2014) Tomomi Ueda et al. CRITICAL CARE MEDICINE
- Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages
- (2014) Antonio Recchiuti et al. FASEB JOURNAL
- A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
- (2014) M.W. Konstan et al. Journal of Cystic Fibrosis
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Characterisation of Leukocytes in a Human Skin Blister Model of Acute Inflammation and Resolution
- (2014) William Jenner et al. PLoS One
- Plasma Metabolomics in Human Pulmonary Tuberculosis Disease: A Pilot Study
- (2014) Jennifer K. Frediani et al. PLoS One
- Resolution of inflammation: an integrated view
- (2013) Almudena Ortega-Gómez et al. EMBO Molecular Medicine
- Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response
- (2013) F. Chen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
- (2012) Sriram Krishnamoorthy et al. AMERICAN JOURNAL OF PATHOLOGY
- Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci
- (2012) Lucy V. Norling et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and safety of 15(R/S)-methyl-lipoxin A4in topical treatment of infantile eczema
- (2012) S.-H. Wu et al. BRITISH JOURNAL OF DERMATOLOGY
- Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
- (2012) A. P. Rogerio et al. JOURNAL OF IMMUNOLOGY
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
- (2011) Gustavo Matute-Bello et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- MicroRNAs and the resolution phase of inflammation in macrophages
- (2011) Muhammad M. Alam et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli
- (2011) Christine D. Palmer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Resolvin D1 protects mice from LPS-induced acute lung injury
- (2011) Bin Wang et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
- (2010) Antonio Recchiuti et al. FASEB JOURNAL
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence
- (2009) Alessandra Bragonzi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia
- (2009) A. Y. Koh et al. INFECTION AND IMMUNITY
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
- (2009) Matthew Spite et al. NATURE
- Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
- (2009) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation
- (2008) Oliver Haworth et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now